Hidradenitis suppurativa outcome measures and treatment goals

Br J Dermatol. 2014 Dec;171(6):1293-4. doi: 10.1111/bjd.13396.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male
  • Severity of Illness Index*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized